Literature DB >> 34402981

Development and validation of a preoperative "difficulty score" for laparoscopic transabdominal adrenalectomy: a multicenter retrospective study.

Laura Alberici1,2, Alessandro M Paganini3, Francesco Minni1,2, Guido Alberto Massimo Tiberio4, Claudio Ricci5,6,7, Andrea Balla3, Zeno Ballarini4, Monica Ortenzi8, Giovanni Casole4, Silvia Quaresima3, Guido Di Dalmazi1,9, Pietro Ursi3, Marie Sophie Alfano4, Saverio Selva2, Riccardo Casadei1,2, Carlo Ingaldi1,2, Giovanni Lezoche8, Mario Guerrieri8.   

Abstract

BACKGROUND: A difficulty score for laparoscopic adrenalectomy (LA) is lacking in the literature. A retrospective cohort study was designed to develop a preoperative "difficulty score" for LA.
METHODS: A multicenter study was conducted involving four Italian tertiary centers for adrenal disease. The population was randomly divided into two subsets: training group and validation one. A multicenter study was undertaken, including 964 patients. Patient, adrenal lesion, surgeon's characteristics, and the type of procedure were studied as potential predictors of target events. The operative time (pOT), conversion rate (cLA), or both were used as indicators of the difficulty in three multivariate models. All models were developed in a training cohort (70% of the sample) and validated using 30% of patients. For all models, the ability to predict complicated postoperative course was reported describing the area under the curve (AUCs). Logistic regression, reporting odds ratio (OR) with p-value, was used.
RESULTS: In model A, gender (OR 2.04, p = 0.001), BMI (OR 1.07, p = 0.002), previous surgery (OR 1.29, p = 0.048), site (OR 21.8, p < 0.001) and size of the lesion (OR 1.16, p = 0.002), cumulative sum of procedures (OR 0.99, p < 0.001), extended (OR 26.72, p < 0.001) or associated procedures (OR 4.32, p = 0.015) increased the pOT. In model B, ASA (OR 2.86, p = 0.001), lesion size (OR 1.20, p = 0.005), and extended resection (OR 8.85, p = 0.007) increased the cLA risk. Model C had similar results to model A. All scores obtained predicted the target events in validation cohort (OR 1.99, p < 0.001; OR 1.37, p = 0.007; OR 1.70, p < 0.001, score A, B, and C, respectively). The AUCs in predicting complications were 0.740, 0.686, and 0.763 for model A, B, and C, respectively.
CONCLUSION: A difficulty score based on both pOT and cLA (Model C) was developed using 70% of the sample. The score was validated using a second cohort. Finally, the score was tested, and its results are able to predict a complicated postoperative course.
© 2021. The Author(s).

Entities:  

Keywords:  Difficulty score; Laparoscopic adrenalectomy; Postoperative complications

Mesh:

Year:  2021        PMID: 34402981      PMCID: PMC9001553          DOI: 10.1007/s00464-021-08678-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


Since it was first described in 1992 by Gagner et al. [1-4], laparoscopic adrenalectomy (LA) has become the standard treatment for most adrenal lesions. Nevertheless, it requires appropriate knowledge of abdominal and retroperitoneal anatomy, proven expertise, and technical skills to avoid surgical complications of the surgical procedure [5-7]. According to Guidelines [8, 9], LA’s indications include small to medium-sized (≤ 6 cm) benign adrenal tumors, both functioning and non-functioning, whereas a laparoscopic approach to suspected or proven adrenal cortical carcinoma and large adrenal masses is yet controversial. At present, several studies have compared the outcomes of different approaches to adrenalectomy [10-16] without remarkable differences. On the other hand, some differences between the first and second generation of laparoscopic surgeons have been demonstrated, remarking a tutor’s role during the training period [17]. However, a “difficulty score” for LA is lacking in the literature. The aim of this study was to develop a preoperative “difficulty score,” analyzing a large series of patients who underwent LA in high-volume tertiary centers.

Methods

A multicenter retrospective observational study was undertaken at the Departments of General Surgery of Bologna (Alma Mater Studiorum—Policlinico S. Orsola-Malpighi), Brescia (Università di Brescia—ASST Spedali Civili), Ancona (Università Politecnica delle Marche), and Roma (Università La Sapienza). All of them are referral centers for adrenal surgery in Italy and have prospectively maintained databases. For each case, the indication for surgical treatment was approved by a multi-disciplinary team, including surgeons, endocrinologists, radiologists, and pathologists dedicated to adrenal diseases. The anesthesiologist evaluation completed the preoperative risk stratification. Data were extrapolated from prospectively collected databases and managed according to Institutional rules, with the patient's consent. All patients undergoing LA from January 1994 to September 2020 were included in the study. Patients who underwent adrenalectomy with an open approach, exploratory laparoscopy, or surgery for recurrence of disease after LA were a priori excluded. The authors screened 976 records, and 12 patients were excluded for incomplete data. In the final analysis, the authors included 964 patients. For each record, the following perioperative data were extracted: characteristics of the patient (gender, age, body mass index, ASA score, comorbidities, previous abdominal surgery, presence of symptoms); characteristics of the adrenal lesion (side, size, presumptive diagnosis of functioning or non-functioning and benign or malignant lesion based on clinical–radiological data); characteristics of the surgeon (cumulative sum of procedures performed, distinction in a junior or senior surgeon [17]); characteristics of the planned procedure (need for extended resection or other surgical procedures); intraoperative data (operative time, laparoscopic approach with or without need for conversion, blood loss); postoperative data such as complications according to Clavien–Dindo classification [18], (CDC) resumption of enteral feeding, need for intensive care in ICU, length of ICU stay, length of hospitalization, 90 days mortality, and histological diagnosis. It should be noted that the cumulative sum of procedures (CUSUM) was described for each surgeon as a progressive ordinal number. Thus, CUSUM reflects the experience of each operator at the time of each procedure.

Statistical analysis

All categorical variables were reported as frequencies and percentages, whereas continuous variables were reported as the median and interquartile range (IQR). An operative time above the 75th percentile (pOT) or conversion to open surgery (cLA) was considered indicative of difficulty. A complicated postoperative course > II CDC class was used to test the utility of difficulty scores. Three predictive models were built: (1) model A, in which all preoperative factors predicting pOT were studied; (2) model B, in which all preoperative factors predicting cLA were studied; (3) model C, in which all preoperative factors predicting both the events were studied. The analysis was carried out in three steps. Firstly, preoperative variables were pre-selected using the least absolute shrinkage and selection operator (LASSO) method [19]. For the subsequent two steps, the cohort was divided into a training (including 70% of patients) and a validation cohort (including the remaining 30%). Patients were casually distributed, independently from the center and the date of surgery, in the two subsets by a random number generator to avoid any time-depending bias. Secondly, all models were analyzed in a training cohort (70% of patients). All models were graphically represented by a nomogram [20] and were converted into a score. A validation was obtained using the remaining 30% of patients (validation cohort) in the third step. Calibration was made using the post-regression estimation of the marginal values. For each score, the diagnostic accuracy (AUC) was described and interpreted as follows: excellent > 0.9, good between 0.8–0.9, fair between 0.7 and 0.8, poor between 0.6 and 0.7, and failed < 0.6. The three models' utility was tested to predict a severe complicated postoperative. All analysis was made using logistic regression reporting odds ratio (OR) and standard error (SE). STATA 14 software (StataCorp.) 2011 was used to carry out all analyses. All details were exhaustively reported in the Supplementary methods.

Results

The entire cohort included 964 patients undergoing laparoscopic adrenalectomy with a transperitoneal approach. The breakdown by centers was the following: 51.7% of patients (498) from Ancona, 26.1% (252) from Bologna, 12.9% (124) from Brescia, and 9.3% (90) from Rome. One senior surgeon (AMP) participated in the University of Ancona case series from 1994 to 2002 and in the University of Rome case series from 2002 to 2020. Preoperative data are described in Supplementary Table 1. The cohort included 577 (59.9%) female and 387 (40.1%) male patients with a median age of 55 years (43–64, IQR) and a BMI of 26 kg/m2 (23–29, IQR). The distribution of the ASA score was as follows: I for 109 patients (11.3%), II for 526 patients (54.6%), III for 318 patients (33.0%), IV for 11 patients (1.1%). Almost half of the patients (41.1%) have undergone previous abdominal surgery, and 52.8% were symptomatic at diagnosis. The suspected preoperative diagnosis was a benign non-functioning cortical lesion in 291 cases (30.2%); a benign functioning cortical lesion in 397 cases (41.2%), 200 of which (20.8%) associated with Conn disease, 137 (14.2%) associated with Cushing disease or syndrome, 57 (5.9%) associated with “mild autonomous cortisol excess” syndrome, 5 (0.5%) associated with mixed secretion of mineralocorticoids and glucocorticoids, and 3 (0.3%) associated with secretion of androgens. In 190 cases (19.7%), the preoperative diagnosis was pheochromocytoma and in 86 cases (8.9%), malignant lesion. Overall, the series included 458 right (47.5%), 479 left (49.7%), and 27 bilateral (2.8%) adrenalectomies. The median overall tumor size was 3.5 cm (2.5–5, IQR). The median cumulative sum of procedures per surgeon was 146 (52–269, IQR). In 144 cases (14.9%), surgery was carried out by a junior surgeon and in 820 cases (85.1%) by a senior surgeon. Only in 10 (1.1%) and 25 (2.6%) cases, extended resection or associated surgical procedures were planned, respectively. The postoperative results are summarized in Supplementary Table 2. The median operative time was 100 (75–140) minutes, and the conversion rate was 5.2% (50 cases). In the majority of patients (945, 98.1%), postoperative complications were absent or mild (grade I or II, according to Clavien–Dindo classification). Twelve patients (1.2%) required percutaneous radiological procedures, and 5 (0.5%) required readmission to the ICU as a consequence of an adverse event (grade III and IV according to Clavien–Dindo, respectively). The reoperation rate was 0.6% (6), and the 90-day mortality rate was 0.2% (2 cases). Perioperative blood transfusions were required in 3.5% of patients. The median duration of hospital stay was 4 days (3–6, IQR). Histology of the removed lesions showed that 56.6% were benign cortical lesions, 19.7% were medullary lesions, 6.5% were adrenal metastasis, 5.2% were myelolipomas, 4.4% were adrenocortical carcinomas, 2.9% were cystic lesions, 2.9% were collision tumors, 1.2% other malignancy, and 0.5% were inflammatory lesions.

First step: preselection of the covariates

The covariates potentially predicting model A (pOT) were age, gender, presence of symptoms, clinical–radiological diagnosis, side of the lesion, BMI, ASA score, previous surgery, lesion size, type of surgeon, CUSUM, and associated or extended surgery. The optimal Lambda value was 0.037. The selection process is shown in Supplementary Fig. 1, panel A. The covariates potentially predicting model B (cLA) were the presence of symptoms, clinical–radiological diagnosis, side of the lesion, BMI, ASA score, previous surgery, lesion size, type of surgeon, and associated or extended surgery. The optimal Lambda value was 6.113. The selection process is shown in Supplementary Fig. 1, panel B. The covariates potentially predicting model C (pOT or cLA) were the same of model A. The optimal Lambda value was 0.034. The selection process is shown in Supplementary Fig. 1, panel C.

Second step: analysis on training cohort

The multivariate analysis on a cohort of 679 patients (70% of the total) is reported in Tables 1, 2, and 3 for models A, B, and C, respectively.
Table 1

Factors predicting an operative time over 75th percentile (training set, N = 679)

ParametersOR ± SEp-valueStep exclusion
Gender (Female vs. male)2.04 ± 0.450.001Final
Age (for each year)0.98 ± 0.010.1894th
BMI (for each Kg/m2)1.07 ± 0.020.002Final
ASA score (for each class)1.29 ± 0.220.1265th
Previous surgery (No vs. yes)1.53 ± 0.330.048Final
Symptoms (No vs. yes)0.72 ± 0.160.1463rd
Clinical and radiological diagnosis2nd
 Non-functioning benign lesionReferent
 Functioning benign lesion1.21 ± 0.380.516
 Pheochromocytoma1.71 ± 0.630.142
 Malignant lesion1.19 ± 0.550.690
SideFinal
 RightReferent
 Left1.12 ± 0.230.590
 Bilateral21.8 ± 17.6 < 0.001
Size (for each cm)1.16 ± 0.060.002Final
Type of surgeon (Junior vs. senior)0.97 ± 0.040.4681st
Cumulative sum of procedures0.99 ± 0.01 < 0.001Final
Extended resection planned (No vs. yes)26.72 ± 24.67 < 0.001Final
Others surgical procedures planned (No vs. yes)4.32 ± 2.610.015Final

OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score

Table 2

Factors predicting conversion to open surgery (training set, N = 679)

ParametersOR ± SEp-valueStep exclusion
BMI (for each Kg/m2)1.01 ± 0.040.9002nd
ASA score (for each class)2.86 ± 0.890.001Final
Previous surgery (No vs. yes)1.41 ± 0.550.3765th
Symptoms (No vs. yes)1.03 ± 0.550.9941st
Diagnosis7th
 Non-functioning benign lesionReferent
 Functioning benign lesion0.41 ± 0.210.082
 Pheochromocytoma0.23 ± 0.180.063
 Malignant lesion2.52 ± 1.270.068
Side4th
 RightReferent
 Left0.71 ± 0.290.415
 Bilateral2.06 ± 1.930.440
Size (for each cm)1.20 ± 0.070.005Final
Type of surgeon (Junior vs. senior)1.05 ± 0.070.4793rd
Extended resection planned (No vs. yes)8.85 ± 7.200.007Final
Others surgical procedures planned (No vs. yes)2.64 ± 2.180.2396th

OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score

Table 3

Factors predicting operative time over 75th percentile or conversion to open surgery (training set, N = 679)

ParametersOR ± SEp-valueStep exclusion
Gender (Female vs. male)1.87 ± 0.390.003Final
Age (for each year)0.98 ± 0.010.1173rd
BMI (for each Kg/m2)1.07 ± 0.02 < 0.001Final
ASA score (for each class)1.33 ± 0.210.0745th
Previous surgery1.56 ± 0.320.032Final
Symptoms (No vs. yes)0.72 ± 0.150.1134th
Diagnosis2nd
 Non-functioning benign lesionReferent
 Functioning benign lesion1.16 ± 0.360.619
 Pheochromocytoma1.55 ± 0.540.217
 Malignant lesion1.43 ± 0.600.400
SideFinal
 RightReferent
 Left1.01 ± 0.210.929
 Bilateral15.15 ± 11.26 < 0.001
Size (for each cm)1.15 ± 0.050.002Final
Type of surgeon (Junior vs. Senior)0.98 ± 0.030.5801st
Cumulative sum of procedures0.99 ± 0.01 < 0.001Final
Extended resection planned (No vs. yes)12.24 ± 10.500.003Final
Others surgical procedures planned (No vs. yes)4.67 ± 2.750.009Final

OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score

Factors predicting an operative time over 75th percentile (training set, N = 679) OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score Factors predicting conversion to open surgery (training set, N = 679) OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score Factors predicting operative time over 75th percentile or conversion to open surgery (training set, N = 679) OR odds ratio, SE standard error, BMI Body Mass Index, ASA American Society of Anesthesiologists score In model A (pOT), male gender (OR 2.04, p = 0.001), BMI (OR 1.07 for each Kg/m2, p = 0.002), previous surgery (OR 1.29, p = 0.048), bilateral site of lesions (OR 21.8, p < 0.001), size of the lesion (OR 1.16 for each cm, p = 0.002), cumulative sum of procedures (OR 0.99, p < 0.001), extended resection (OR 26.72, p < 0.001), and associated surgical procedures (OR 4.32, p = 0.015) significantly influenced the operative time. The nomogram obtained from model A is shown in Fig. 1. Score A ranges from a minimum of 0 to a maximum of 33.5 points. In model B (cLA), ASA score (OR 2.86, p = 0.001), size of the lesion (OR 1.20 for each cm, p = 0.005), and the need for extended resection (OR 8.85, p = 0.007) significantly increased the risk of conversion. The nomogram obtained from model B is shown in Fig. 2. Score B ranges from a minimum of 0 to a maximum of 23 points. In model C (pOT or cLA), male gender (OR 1.87, p = 0.003), BMI (OR 1.07 for each Kg/m2, p = 0.001), previous surgery (OR 1.56, p = 0.032), bilateral site of lesions (OR 15.15, p < 0.001), size of lesion (OR 1.15 for each cm, p = 0.002), cumulative sum of procedures (OR 0.99, p < 0.001), extended resection (OR 12.24, p = 0.003), and associated surgical procedures (OR 4.67, p = 0.009) were found to have significant relationship with the operative time or the conversion rate. The nomogram obtained from model C is shown in Fig. 3. Score C ranges from a minimum of 0 to a maximum of 33.5 points. The AUCs were 0.833 ± 0.016, 0.710 ± 0.048, and 0.809 ± 0.019 fo Score A, B, and C, respectively (Supplementary Fig. 2 panel A, B, and C).
Fig. 1

Nomogram of model A (operative time over 75th percentile)

Fig. 2

Nomogram of model B (converted procedure)

Fig. 3

Nomogram of model C (operative time over 75th percentile or converted procedure)

Nomogram of model A (operative time over 75th percentile) Nomogram of model B (converted procedure) Nomogram of model C (operative time over 75th percentile or converted procedure)

Third step: analysis of the validation and test cohort

Scores A, B, and C were validated on a cohort of 285 patients (30% of the total). Score A has been proven to significantly predict an operative time extension's increased risk beyond 140 min (OR 1.99 ± 0.19 for each point, p < 0.001). Supplementary Fig. 3 panel A shows the curve’s trend representing Score A. Score B has been proven to significantly predict the increased risk of conversion (OR 1.37 ± 0.16 for each point, p = 0.007). Supplementary Fig. 3 panel B shows the curve trend representing Score B. Score C has been proven to significantly predict the increased risk of an operative time extension beyond 140 min or conversion (OR 1.70 ± 0.13 for each point, p < 0.001). Supplementary Fig. 3 panel C shows the trend of the curve representing Score C. The AUCs of the three models were 0.820 ± 0.015 for score C, 0.819 ± 0.015 for score A, and 0.6333 ± 0.0208 for score B (Supplementary Fig. 4 panel A, B, and C). All three models (A, B, and C) were significantly related (p < 0.001) to a complicated postoperative course defined as CDC class > II: OR 1.29 ± 0.81, 1.72 ± 0.23, and 1.25 ± 0.06 for Score A, B, and C, respectively. The AUCs values in predicting severe postoperative complications were 0.740 ± 0.071, 0.686 ± 0.069, and 0.763 ± 0.415 for Model A, B, and C, respectively (Fig. 4).
Fig. 4

Receiver operating characteristic (ROC) curves for model A, B, and C in predicting complicated postoperative course (Clavien–Dindo class > 2)

Receiver operating characteristic (ROC) curves for model A, B, and C in predicting complicated postoperative course (Clavien–Dindo class > 2)

Discussion

The present study demonstrated that some preoperative parameters are useful to predict the difficulty of LA. In this study, 964 laparoscopic adrenalectomies performed in four high-volume centers are described. To our knowledge, this is one of the largest cohorts in which the difficulty of LA was evaluated. Similar to other experiences [21-23], the difficulty was measured using the operative time and conversion rate. The severe postoperative complication rate was used to confirm the utility of the scores. The perioperative transfusion rate was not used as an indicator of difficulty because transfusions were relatively rare events (3.5%) related to the conversion rate. Thus, a model based on transfusion rate could overlap the model based on conversion rate without a gain in statistical power. Three separate models were developed: one for the operative time (A), one for the conversion (B), and one for both (C). Each model was studied in a training cohort (70% of the sample) and confirmed in a validation cohort (30% of the sample). The results observed in the training cohort were those expected based on literature data both for operative time [14–17, 23–28] and conversion rate [20-22]. Indeed, male gender, high BMI, previous abdominal surgery, bilaterality of lesion, size of the lesion [29-32], associated surgical procedures, and need for extended resections prolonged the operative time, increasing the probability of overcoming the 75th percentile. The surgeon’s experience, on the contrary, reduced the probability of a prolonged operative time. The lesion’s size, the ASA score, and the need for extended resection increased conversion probability. All three models are clinically plausible, easily computable using a simple nomogram (Figs. 1, 2, 3), and provide a numerical score related to the target events' probability. Nevertheless, models A and C have good accuracy, whereas B has fair accuracy. The models were validated and calibrated using the second cohort of patients, confirming the results’ statistical plausibility. In the validation cohort, the AUCs of models A and C were confirmed to be good, correctly classifying eight patients every ten tested. On the contrary, model B was not so accurate, correctly classifying only six patients every ten. Therefore, the most useful model to predict a difficult LA seems to be model C because it demonstrated a high AUC and, at the same time, the ability to predict both adverse events (conversion or prolonged operative time). This finding did not surprise: a model based only on the conversion rate could not include all “difficult” procedures. In other words, not all challenging procedures were converted even if performed by a skilled laparoscopic surgeon. A second interesting result was that both A and C models take into consideration many types of factors. Indeed, the scores included both patient and disease characteristics, not forgetting the type of procedures planned and the surgeon’s experience. The score could practically help the chief surgeon plan the procedures and proper patient counseling. The models’ utility was further underlined by the correlation between A and C scores with the probability of a complicated postoperative course. This study has some limitations. First, the design of the study was retrospective. However, all databases come from high-volume centers and are prospectively maintained. Moreover, all postoperative data suggested the high quality of surgery with very low conversion and postoperative complication rates. A second limitation was the large enrollment period and the relative changes in surgeon training and medical devices over the last 20 years. According to the period in which they were trained, the bias was partially mitigated and studied by dividing the surgeons into first- and second-generation surgeons [17]. Moreover, all time-depending bias, such as different distribution of significant factors, was overcome by the study design. Indeed, the entire cohort was randomly divided, independently from the center and date of surgery, in a training and validation cohort. A third limitation was the low number of target events (converted or prolonged procedures) used to build the scores. Indeed, the low number of events could affect the robustness of multivariate models. Nevertheless, the LASSO approach's use solved the overfitting, reducing, when necessary, the number of covariates for the multivariates analysis. A further limitation was the applicability of the difficulty score only in transperitoneal approaches. All involved centers performed LA using the anterior or lateral transperitoneal approach, and for this reason, the model was not validated for the retroperitoneal approach. In conclusion, we reported, validated, and tested a difficulty score for laparoscopic adrenalectomy for the first time. The obtained models, particularly model C, could predict two critical events: conversion to open surgery and prolonged operative time. The score for each model corresponds to the probability that the target event may occur. It is simple to calculate preoperatively, practical to use, and could be used not only for the surgical team’s choice but also to predict and avoid a complicated postoperative course. An external validation would be recommended to confirm these results further. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 15 kb) Supplementary file2 (DOCX 56807 kb)
  31 in total

Review 1.  Does tumor size influence the outcome of laparoscopic adrenalectomy?

Authors:  A M Kazaryan; T Mala; B Edwin
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2001-02       Impact factor: 1.878

Review 2.  Retroperitoneal versus transperitoneal laparoscopic adrenalectomy in adrenal tumor: a meta-analysis.

Authors:  Wei Chen; Fei Li; Dingnan Chen; Yongtong Zhu; Chengwu He; Yuejun Du; Wanlong Tan
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2013-04       Impact factor: 1.719

3.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

4.  Patients criteria determining difficulty of the laparoscopic lateral transperitoneal adrenalectomy. A retrospective cohort study.

Authors:  Michał Natkaniec; Jadwiga Dworak; Michał Pędziwiatr; Magdalena Pisarska; Piotr Major; Marcin Dembiński; Marek Winiarski; Andrzej Budzyński
Journal:  Int J Surg       Date:  2017-05-17       Impact factor: 6.071

Review 5.  Laparoscopic adrenalectomy.

Authors:  Andrew A Gumbs; Michel Gagner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-09       Impact factor: 4.690

6.  Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients.

Authors:  James G Bittner; Victoria M Gershuni; Brent D Matthews; Jeffrey F Moley; L Michael Brunt
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

7.  Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project.

Authors:  Dawn M Elfenbein; John E Scarborough; Paul J Speicher; Randall P Scheri
Journal:  J Surg Res       Date:  2013-04-28       Impact factor: 2.192

8.  Laparoscopic adrenalectomy: ascending the learning curve.

Authors:  D Goitein; G David; Y Mintz; M Yoav; D Gross; P Reissman
Journal:  Surg Endosc       Date:  2004-04-06       Impact factor: 4.584

9.  Single center experience with laparoscopic adrenalectomy on a large clinical series.

Authors:  Giovanni Conzo; Claudio Gambardella; Giancarlo Candela; Alessandro Sanguinetti; Andrea Polistena; Guglielmo Clarizia; Renato Patrone; Francesco Di Capua; Chiara Offi; Mario Musella; Sergio Iorio; Giseppe Bellastella; Daniela Pasquali; Annamaria De Bellis; Antonio Sinisi; Nicola Avenia
Journal:  BMC Surg       Date:  2018-01-11       Impact factor: 2.102

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  2 in total

1.  Perioperative factors influencing the difficulty of retroperitoneal laparoscopic adrenalectomy: a single-center retrospective study.

Authors:  Jinyao Wang; Bin Yang; Shiwei Sun; Yangang Zhang
Journal:  BMC Urol       Date:  2022-02-17       Impact factor: 2.264

2.  High-Volume Center Experience with Laparoscopic Adrenalectomy over Two Decades.

Authors:  Milena Duralska; Jacek Dzwonkowski; Janusz Sierdziński; Sławomir Nazarewski
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.